Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0000950170-24-065395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-28 | 2024-05-23 | TMDX | Lovell Stephanie | Dir | A - Grant | $0.00 | +732 | 1,925 | +61% | $0 |
| D | 2024-05-28 | 2024-05-23 | TMDX | Lovell Stephanie | Dir | A - Grant | $0.00 | +1,154 | 1,154 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-23 | A | A | 732 | $0.00 | 1,925 | D | — | — | (F1) Consists of 732 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-23 | A | A | 1,154 | $0.00 | 1,154 | D | $137.53 · — to 2034-05-23 | 1,154 Common Stock | (F2) The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service. |